Skip to main content

Table 2 Intragroup comparison of Fabry patients

From: Increased urinary CD80 excretion and podocyturia in Fabry disease

Variables No ERT (n: 23) ERT (n: 22) p value
Age (years) 19 (11–75) 38.5 (17–86) 0.02
Gender (males) 4 (14 %) 14 (64 %) 0.01
Time on ERT (months) 0 42 (34–50) <0.0001
eGFR (ml/min/1.73 m2) 141 (60–165) 120.5 (21–148) 0.03
UPCR (g/g) 0.06 (0.02–2.35) 0.11 (0.02–5.68) 0.04
Podocyturia/Cr (cells/g) 34 (4–439) 24 (0–107) 0.45
uCD80/Cr (ng/g) 40 (0–235) 47 (0–2966) 0.7
Mutations D33G, L415P, R227X, A292T, N34D, C801, C326, C647A, C281, G640C, C1244T D33G, L415P, R227X, A292T, N34D, D264Y, D155H, L180F  
  1. Significant values (p < 0.05)